INDIVIDUAL PEPTIDE PROFILE
SS-31 / Elamipretide
A mitochondria-targeted peptide studied for its interaction with cardiolipin in the inner mitochondrial membrane, and investigated in human trials for rare mitochondrial and neuromuscular conditions.
WHAT IT IS
SS-31 is a small synthetic peptide that concentrates in the inner mitochondrial membrane. Its clinical development name is elamipretide, and it has been studied by Stealth BioTherapeutics in a series of human trials.
It belongs to a class sometimes called Szeto-Schiller peptides, named after the researchers who first described them.
Unlike many compounds in this library, elamipretide has been through registered clinical trials with published results, including studies in rare mitochondrial diseases.
HOW IT WORKS / MECHANISM BEING STUDIED
Elamipretide is thought to bind cardiolipin, a phospholipid found in the inner mitochondrial membrane that is essential to the structure of the electron transport chain.
By stabilizing cardiolipin-containing membranes, the hypothesis is that mitochondria maintain more efficient electron transport, produce ATP more effectively and leak fewer reactive oxygen species.
Reduced oxidative stress and better-organized mitochondrial architecture are the two mechanistic themes that run through nearly all of the research on this compound.
WHAT RESEARCHERS ARE STUDYING IT FOR
Human and preclinical research has examined:
- Primary mitochondrial myopathy and exercise tolerance
- Barth syndrome, a rare genetic cardiolipin disorder
- Heart failure and cardiac mitochondrial dysfunction
- Certain ophthalmic conditions involving retinal metabolism
- Kidney injury and ischemia-reperfusion models
- Age-related mitochondrial decline in skeletal muscle
POTENTIAL AREAS OF RESEARCH INTEREST
- Rare genetic mitochondrial disorders with clearly defined biology
- Cardiac and skeletal muscle conditions involving energy failure
- Oxidative stress in age-related tissue dysfunction
- Objective biomarkers of mitochondrial function in humans
WHAT THE EVIDENCE ACTUALLY SHOWS
Preclinical research has been consistently supportive, showing improved mitochondrial structure and function across multiple animal and cell models.
Human results have been considerably more mixed. Some trials have reported improvements on selected measures, while pivotal studies in primary mitochondrial myopathy did not meet their primary endpoints, and the regulatory path has been difficult.
That pattern, strong preclinical signal with inconsistent human outcomes, is common in mitochondrial medicine and is exactly why careful reading matters.
Mitochondrial research in this area is scientifically interesting, though it has not established broad claims about reversing aging or increasing energy in healthy people.
Mitochondria and the energy claim
MITOCHONDRIAL SCIENCE IS NOT AN ENERGY GUARANTEE
Mitochondria produce cellular energy, so it is easy to assume that anything targeting mitochondria will make a person feel more energetic.
Subjective energy in healthy adults is driven far more by sleep, training load, nutrition, thyroid and iron status, mood and medical conditions than by a single mitochondrial pathway.
The human trials for elamipretide have focused on defined disease states with measurable mitochondrial dysfunction, not on healthy adults looking for more day-to-day energy.
Research Reality Check
What we know
Elamipretide is a mitochondria-targeted peptide with a plausible, well-described mechanism involving cardiolipin, supported by substantial preclinical evidence and studied in registered human clinical trials.
What remains uncertain
Whether it produces reliable clinical benefit in humans. Pivotal trials have produced mixed results, it is not FDA-approved, and there is no evidence supporting use in healthy adults for energy, performance or longevity.
Educational commentary, not personal testimonial
The Balanced Body Lifestyle Take
SS-31 has our attention because it points directly at mitochondrial function, cellular energy and how tissues hold up over time. Energy at the cellular level connects to almost everything we coach, so we keep watching this one.
If SS-31 has caught your attention or you would like to understand it better, reach out to us. We can talk about what interests you, answer your questions, and look at what is currently happening in the peptide world.
QUESTIONS PEOPLE OFTEN ASK
Peptide Education Consultation
Interested in learning more about peptides? Schedule an educational consultation with Vince Angelo to discuss the information and ask questions.
Schedule an Educational ConsultationEDUCATIONAL NOTICE
The Balanced Body Lifestyle™ provides peptide and wellness information for educational purposes only. Content is intended to help readers better understand emerging research, established evidence and areas of scientific uncertainty. It is not medical advice, diagnosis, treatment guidance or a recommendation to use any medication, peptide or research compound. Decisions involving prescription medications or investigational compounds should be discussed with a qualified healthcare professional.
THE BALANCED BODY LIFESTYLE
A healthy life is built on balance.